Results 111 to 120 of about 57,206 (164)

Sphingolipid Remodeling and Extracellular Vesicle Signatures Reflect Disease Severity in Facioscapulohumeral Dystrophy Driven by Mitochondrial Dysfunction and Endoplasmic Reticulum Stress. [PDF]

Antioxidants (Basel)
Moriggi M, Ruggiero L, Torretta E, Zoppi D, Arosio B, Fiorillo C, Nigro V, Capitanio D, Gelfi C.   +8 more
europepmc   +1 more source

Motion sensor-acquired reachable workspace correlates with patient-reported upper extremity activities of daily living (ADL) function in facioscapulohumeral dystrophy. [PDF]

Muscle Nerve, 2021
Hatch MN, Kurillo G, Chan V, Han JJ.
europepmc   +1 more source

Interleukin-6 as a Key Biomarker in Facioscapulohumeral Dystrophy: Evidence From Longitudinal Analyses. [PDF]

Ann Clin Transl Neurol
Pini J, Martinuzzi E, Dhifallah S, Slioui A, Puma A, Villa L, Cavalli M, Ezaru A, Garcia J, Gambella M, Torre F, Pavan LJ, Glaichenhaus N, Sacconi S.   +13 more
europepmc   +1 more source

A study evaluating differences in 3D upper limb kinematics and surface electromyography measures in adults with and without facioscapulohumeral dystrophy. [PDF]

JSES Rev Rep Tech
Philp F, Seyres M, Emery N, Kulshrestha R, Chadwick EK.   +4 more
europepmc   +1 more source

Overview of facioscapulohumeral dystrophy clinical features and diagnostic pathway.

Contains fulltext : 330353.pdf (Publisher’s version ) (Open Access)Facioscapulohumeral dystrophy is a common muscular dystrophy typically presenting between 15 and 30 years of age and is caused by aberrant DUX4 expression.
Johnson, N., Statland, J., Voermans, N.C., Schoser, B., Camarta, N., Brun, B.N.   +5 more
core   +1 more source

Facioscapulohumeral Dystrophy: Molecular Basis and Therapeutic Opportunities. [PDF]

Cold Spring Harb Perspect Biol
Arends T, Hamm DC, van der Maarel S, Tapscott SJ.   +3 more
europepmc   +1 more source

Spinal fusion in facioscapulohumeral dystrophy for hyperlordosis: A case report. [PDF]

Medicine (Baltimore), 2020
Eren İ, Abay B, Günerbüyük C, Çakmak ÖÖ, Şar C, Demirhan M.   +5 more
europepmc   +1 more source

Deciphering Facioscapulohumeral Dystrophy in the clinical trials era: where are we now? [PDF]

Acta Myol
Torri F, Ciurli B, Rende M, Votta A, Mocciaro E, Karakashi F, Lencioni M, Ferraro E, Filosto M, Gabellini D, Siciliano G, Ricci G.   +11 more
europepmc   +1 more source

P557: Preimplantation genetic diagnosis for facioscapulohumeral muscular dystrophy

Genetics in Medicine Open, 2023
Hagit Shani, Baruch Feldman, Noa Harel Inbar, Haike Reznik-Wolf, Elon Pras   +4 more
doaj   +1 more source

State-of-the-Art and Future Challenges for Nutritional Interventions in Facioscapulohumeral Dystrophy: A Narrative Review. [PDF]

Nutrients
Quintiero V, Crisafulli O, Diotti D, Tupler R, Negro M, Lavaselli E, D'Antona G.   +6 more
europepmc   +1 more source